These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 1722921)

  • 21. [Local screening program for prostate cancer].
    Kotsev R; Kolev N; Stratev S; Mikhailov O
    Khirurgiia (Sofiia); 2000; 56(5-6):52-4. PubMed ID: 11692936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characteristics of prostate cancers detected in a multimodality early detection program. The Investigators of the American Cancer Society-National Prostate Cancer Detection Project.
    Mettlin C; Murphy GP; Lee F; Littrup PJ; Chesley A; Babaian R; Badalament R; Kane RA; Mostofi FK
    Cancer; 1993 Sep; 72(5):1701-8. PubMed ID: 7688658
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Endosonography of the prostate].
    Hammerer P
    Urologe A; 1991 Nov; 30(6):370-7. PubMed ID: 1722920
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Consensus conference. The detection of localized cancer of the prostate. Paris, 8-9 December 1989].
    Ann Urol (Paris); 1990; 24(1):5-8. PubMed ID: 1690964
    [No Abstract]   [Full Text] [Related]  

  • 25. Can digital rectal examination or transrectal ultrasonography biopsy findings predict the side of nodal metastasis in prostate cancer?
    Spiess PE; Busby JE; Jordan JJ; Steinberg JR; Bassett RL; Davuluri R; Burt K; Troncoso P; Lee AK; Taylor SH; Pisters LL
    Urol Oncol; 2008; 26(1):25-30. PubMed ID: 18190826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictive value of the anatomical location of ultrasound-guided systematic sextant prostate biopsies for the nodal status of patients with localized prostate cancer.
    Dunzinger M; Sega W; Madersbacher S; Schorn A
    Eur Urol; 1997; 31(3):317-22. PubMed ID: 9129923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Diagnostic imaging of the prostate cancer].
    Mocarska A; Starosławska E; Iwonna ZC; Brzozowska A; Łosicki M; Stasiewicz D; Burdan F
    Pol Merkur Lekarski; 2012 Dec; 33(198):357-63. PubMed ID: 23437709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Possibilities of using magnetic resonance imaging-transrectal ultrasound fusion in the diagnosis of recurrent prostate cancer].
    Kapustin VV
    Vestn Rentgenol Radiol; 2011; (3):53-6. PubMed ID: 22288135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic sextant biopsies in 651 patients referred for prostate evaluation.
    Hammerer P; Huland H
    J Urol; 1994 Jan; 151(1):99-102. PubMed ID: 7504750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The importance of tumor palpability and transrectal ultrasonographic appearance in the contemporary clinical staging of prostate cancer.
    Eisenberg ML; Cowan JE; Davies BJ; Carroll PR; Shinohara K
    Urol Oncol; 2011; 29(2):171-6. PubMed ID: 19362864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The diagnosis of prostatic carcinoma].
    Hammerer P; Huland H
    Fortschr Med; 1991 Sep; 109(26):512-7. PubMed ID: 1723711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Screening for cancer of the prostate using prostate-specific antigen].
    Toubert ME; Schlageter MH; Bron J; Teillac P; Le Duc A; Najean Y
    Presse Med; 1990 Jun; 19(24):1139-42. PubMed ID: 1694583
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The value of prostatic specific antigen in the early diagnosis of prostatic cancer: a Greek view.
    Deliveliotis C; Alivizatos G; Karayiannis A; Kontothanasis D; Makrychoritis K; Lysiotis P; Dimopoulos MA
    Br J Urol; 1995 May; 75(5):637-41. PubMed ID: 7542133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Staging of prostate cancer. Accuracy of transrectal ultrasound enhanced by prostate-specific antigen.
    Wolf JS; Shinohara K; Narayan P
    Br J Urol; 1992 Nov; 70(5):534-41. PubMed ID: 1281724
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of transrectal ultrasound in preoperative staging of prostate cancer.
    Colombo T; Schips L; Augustin H; Gruber H; Hebel P; Petritsch PH; Hubmer G
    Minerva Urol Nefrol; 1999 Mar; 51(1):1-4. PubMed ID: 10222753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for prostate cancer using prostate-specific antigen alone as a first-line checkup parameter: results of the health checkup system.
    Uchida K; Takeshima H; Akaza H; Ono Y
    Jpn J Clin Oncol; 2000 Feb; 30(2):95-100. PubMed ID: 10768873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is preoperative transrectal ultrasonography of value in localised prostatic carcinoma? A blind comparative study between preoperative transrectal ultrasonography and the histopathological radical prostatectomy specimen.
    Vijverberg PL; Giessen MC; Kurth KH; Dabhoiwala NF; de Reijke TM; van den Tweel JG
    Eur J Surg Oncol; 1992 Oct; 18(5):449-55. PubMed ID: 1426295
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate cancer: comparison of transrectal US and digital rectal examination for screening.
    Lee F; Littrup PJ; Torp-Pedersen ST; Mettlin C; McHugh TA; Gray JM; Kumasaka GH; McLeary RD
    Radiology; 1988 Aug; 168(2):389-94. PubMed ID: 3293108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of the period between biopsy and diffusion-weighted magnetic resonance imaging on cancer staging in localized prostate cancer.
    Park KK; Lee SH; Lim BJ; Kim JH; Chung BH
    BJU Int; 2010 Oct; 106(8):1148-51. PubMed ID: 20346052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Staging accuracy of magnetic resonance imaging versus transrectal ultrasound in stages A and B prostatic cancer.
    Vapnek JM; Hricak H; Shinohara K; Popovich M; Carroll P
    Urol Int; 1994; 53(4):191-5. PubMed ID: 7855937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.